Skuldtech

About:

Skuldtech innovates diagnostics associated with new treatments for cancer and neurodegenerative and infectious diseases.

Website: http://skuldtech.com

Top Investors: Bpifrance

Description:

Skuldtech is specialized in the discovery of new Biomarkers and the development of Diagnostics focused on personalized medicine applications. This expertise enables the company to provide genomic, pharmacogenomic and transcriptomic services, as well as innovative diagnostics associated with new treatments, especially in cancer, neurodegenerative and infectious diseases.

Total Funding Amount:

1M EUR

Headquarters Location:

New York, New York, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)skuldtech.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2013-09-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai